May 18, 2010

The Food and Drug Administration has approved a new biotech drug made by Roche U.S....

May 16, 2010

The cancer drug arm of Eli Lilly plans to show data from more than 50...

May 2, 2010

A combination of a biotech drug and laser treatment may improve vision in patients with...

March 22, 2010

A Food and Drug Administration advisory committee declined to recommend approval for a cancer drug...

March 17, 2010

Roche leaders appear confident about their company’s research and development position, with several investigational drugs...

March 11, 2010

A late-stage clinical trial of a Genentech drug for men with late-stage prostate cancer has...

March 11, 2010

Two clinical trials of a Pfizer drug for treating advanced breast cancer have failed, Pfizer...

March 9, 2010

Abbott will acquire Facet Biotech for $450 million, the drug maker announced Wednesday....

March 7, 2010

Roche and Biogen Idec are suspending trials of a drug for treating autoimmune disorders amid...

February 24, 2010

A late-stage clinical trial of a drug by Genentech indicates that combining it with chemotherapy...

February 21, 2010

The high prices of drugs made by Johnson & Johnson and Abbott will drive the...

February 18, 2010

The Food and Drug Administration has approved a drug made by Roche subsidiary Genentech and...

February 8, 2010

An investigational drug made by Amgen for treating prostate cancer that had spread to the...

January 11, 2010

Biogen Idec hopes to win approval for a multiple sclerosis drug in Canada and the...

January 10, 2010

The Food and Drug Administration has approved a Genentech drug for treating rheumatoid arthritis, the...

January 6, 2010

Two drug makers have entered an agreement to develop a drug designed to treat melanoma....

January 3, 2010

A new report by Decision Resources revealed that a biological therapy with a mechanism of...

August 20, 2009

Most consumers may not know a lot about biosimilar equivalence, immunogenicity or what “monoclonal antibody”...